Abstract
The continuing discovery and development of β-lactams as antibio-tics has had an unparalleled impact on the overall health and well-being of society. Recently, appropriately substituted cephalo-sporins were shown to be potent inhibitors of elastase1, suggesting a novel therapeutic role for the β-lactams in the control of emphysema and other degenerative diseases2,3. We have now solved and partially refined at atomic resolution the structure of a com-plex of porcine pancreatic elastase with the time-dependent irreversible inhibitor 3-acetoxymethyl-7-α-chloro-3-cephem-4-carboxylate-l,l-dioxide tert-butyl ester (I), the most potent of the β-lactam elastase inhibitors yet reported1. (Porcine pancreatic elastase is a close relative of the desired drug target, human polymorphonuclear leukocyte elastase.) A mechanism of action is presented, based on the structure and on biochemical evidence (T.-Y.L. et al., in preparation), which clarifies the operational similarities and differences between β-lactam elastase inhibitors and antibiotics. Features of the reaction include the expulsion of a leaving group at the cephalosporin 3′position and the formation of two covalent bonds with the active site of porcine pancreatic elastase at residues Ser 195 and His 57.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
1. Doherty, J. B. et al. Nature 322, 192–194 (1986). 2. Janoff, A. A. Rev. Med. 36, 207–216 (1985). 3. Stein, R. L., Trainor, D. A. & Wildonger, R. A. Rep. med. Chem. 20, 237–246 (1985). 4. Brown, A. G. / antimicrob. Chemother. 10, 365–372 (1982). 5. Pratt, R. F. & Faraci, W. S. /. Am. chem. Soc. 108, 5328–5333 (1986). 6. Knowles, J. R. Ace. Chem. Res. 18, 97–104 (1985). 7. Boyd, D. B. J. mednl. Chem. 27, 63–66 (1984). 8. Kraut, J. A. Rev. Biochem. 46, 331–358 (1977). 9. Cohen, G. H., Silverton, E. W. & Davies, D. R. /. molec. Biol. 148, 449–479 (1981). 10. Schecter, I. & Berger, A. Biochem. biophys. Res. Commun. 27, 157–162 (1967). 11. James, M. N. G., Sielecki, A. R., Brayer, G. D., Delbaere, L. T. J. & Bauer, C.–A. /. molec. Biol. 144, 43–88 (1980). 12. Cohen, N. C. J. mednl. Chem. 26, 259–264 (1983). 13. Page, M. I. Ace. Chem. Res. 17, 144–151 (1984). 14. Lamotte–Brasseur, J. Dive, G. & Ghuysen, J.–M. Eur. J. med. Chem. 19, 319–330 (1984). 15. Waxman, D. J. & Strominger, J. L. A. Rev. Biochem. 52, 825–869 (1983). 16. Hendrickson, W. A. & Konnert, J. H. Computing in Crystallography (eds Diamond, R., Ramaseshan, S. & Venkatesan, K.) 13.01–13.23 (Indian Academy of Sciences, Bangalore, 1980). 17. Sielecki, A. R. et al. J. molec. Biol. 134, 781–804 (1979). 18. Sawyer, L. et al. J. molec. Biol. 118, 137–208 (1975). 19. McPherson, A. Preparation and Analysis of Protein Crystals (Wiley, New York, 1982). 20. Navia, M. A., Springer, J. P., Poe, M., Boger, J. & Hoogsteen, K. J. biol. Chem. 259, 12714–12717 (1984). 21. Sparks, R. A. Computational Crystallography (ed. Sayre, D.) 1–18 (Clarendon Press Oxford 1982). 22. North, A. C. T., Phillips, D. C. & Mathews, F. S. Ada crystallogr. A 24, 351–359 (1967). 23. Saper, M. thesis, Rice Univ., Houston (1983). 24. Steigemann, W. thesis, Technische Universitat, Munchen (1974). 25. Gund, P., Andose, J. D., Rhodes, J. B. & Smith, G. M. Science 208, 1425–1431 (1980). 26. Jones, T. A. Computational Crystallography (ed. Sayre, D.) 303–317 (Clarendon Press, Oxford, 1982). 27. Bush, B. L. Computers Chem. 8, 1–11 (1984).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Navia, M., Springer, J., Lin, TY. et al. Crystallographie study of a β-lactam inhibitor complex with elastase at 1.84 Å resolution. Nature 327, 79–82 (1987). https://doi.org/10.1038/327079a0
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/327079a0
- Springer Nature Limited
This article is cited by
-
Molecular recognition: Models for drug design
Experientia (1991)